Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: a one year prospective study.
about
Three SIBLINGs (small integrin-binding ligand, N-linked glycoproteins) enhance factor H's cofactor activity enabling MCP-like cellular evasion of complement-mediated attackAssociations between biomarkers of joint metabolism, hand osteoarthritis, and hand pain and function: the Johnston County Osteoarthritis Project.Elevation in circulating biomarkers of cartilage damage and inflammation in athletes with femoroacetabular impingementWhat is the utility of biomarkers for assessing the pathophysiology of hip osteoarthritis? A systematic review.Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritisPrognostic factors of progress of hip osteoarthritis: a systematic review.Cartilage oligomeric matrix protein in monitoring and prognostication of osteoarthritis and its utility in drug developmentSerum levels of YKL-40 and C reactive protein in patients with hip osteoarthritis and healthy subjects: a cross sectional study.Increased serum cartilage oligomeric matrix protein levels and decreased patellar bone mineral density in patients with chondromalacia patellaeUrinary type II collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritis.Urinary CTX-II and glucosyl-galactosyl-pyridinoline are associated with the presence and severity of radiographic knee osteoarthritis in men.Validity and responsiveness of radiographic joint space width metric measurement in hip osteoarthritis: a systematic review.Protein modification by deamidation indicates variations in joint extracellular matrix turnoverPredictors of response to viscosupplementation in patients with hip osteoarthritis: results of a prospective, observational, multicentre, open-label, pilot study.Interleukin-6 and ratio of plasma interleukin-6/interleukin-10 as risk factors of symptomatic lumbar osteoarthritisNew biochemical insights into the pathogenesis of osteoarthritis and the role of laboratory investigations in clinical assessment.The potential value of blood biomarkers of intervertebral disk metabolism in the follow-up of patients with sciatica.Cartilage markers and their association with cartilage loss on magnetic resonance imaging in knee osteoarthritis: the Boston Osteoarthritis Knee Study.Whole-body bone scintigraphy provides a measure of the total-body burden of osteoarthritis for the purpose of systemic biomarker validation.Effect of an exercise and dietary intervention on serum biomarkers in overweight and obese adults with osteoarthritis of the kneeChange in serum measurements of cartilage oligomeric matrix protein and association with the development and worsening of radiographic hip osteoarthritis.Cartilage Oligomeric Matrix Protein (COMP): A Biomarker of Arthritis.TIP39/parathyroid hormone type 2 receptor signaling is a potent inhibitor of chondrocyte proliferation and differentiation.Application of biochemical markers in development of drugs for treatment of osteoarthritis.Biomarkers of cartilage and surrounding joint tissue.Natural history of radiographic hip osteoarthritis: A retrospective cohort study with 11-28 years of followup.Early stages of osteoarthritis: the search for sensitive predictors.Aggrecan and cartilage oligomeric matrix protein in serum and synovial fluid of patients with knee osteoarthritisAlterations of Subchondral Bone Progenitor Cells in Human Knee and Hip Osteoarthritis Lead to a Bone Sclerosis Phenotype.Intramuscular clodronate in erosive osteoarthritis of the hand is effective on pain and reduces serum COMP: a randomized pilot trial-The ER.O.D.E. study (ERosive Osteoarthritis and Disodium-clodronate Evaluation).
P2860
Q28217300-0A471320-1A4C-4479-AFDD-EFED95F40777Q33560900-8E2CB2BF-3ED8-4E11-B2E4-71D8DC8B7A6CQ33724446-42EB8A6B-83AA-4ED6-BDD4-1E348655ED9BQ34459809-FE69D7A6-9B49-4B38-938E-CB3B7831023BQ34894822-D431A85B-6BCE-49F3-9477-FA24B89C3C88Q34968830-36DC1945-6990-44FB-8773-E77C2EE49863Q35041613-BED06524-F414-4EF5-80A1-65DEE5DA86D6Q35548928-A76CBC9C-CC65-4395-A297-2273449B7642Q35551100-8B1BF502-6FF4-4314-8235-B1E4F63AE286Q35552085-C408F058-B327-40F9-9F79-365A4D39A7EFQ35637421-64A178DE-C35D-4E9C-8D2B-602A74483AC2Q35709616-37FE9DB4-0AE8-4C38-922C-4794C8B1FB15Q35762904-FAE6A98A-730D-4457-B773-B2EE1D36323AQ36241176-4185C431-F0EF-491A-B52B-92676DB3927FQ36294719-B4A0C887-E400-4896-A2BC-DB565BB04EB4Q36310851-12286D37-DE21-48F3-9B7E-7F3F4DC0C2E0Q36372359-58E20BD5-C616-458A-A841-AE463F72C9DDQ36401945-8A502A4D-3140-4C28-8AD2-22DC1D67EE19Q36954971-8874A4F7-5BB4-4B71-9268-873B699D9513Q37029663-FDF7D461-407C-4185-94B9-678D827126F2Q37237588-916C79CA-C723-45D3-B24A-63E80592D1FBQ37277626-CBBB6316-2362-4708-B9CD-D44CB2BCD833Q37430782-A0DD315C-32A7-4A9C-8502-80C6EEFD941BQ37677789-517C0626-95FF-488E-9254-A740F01D06C8Q38239828-07DC4E74-F4F7-42D1-9B3B-0A7AF2F5669EQ39752040-E239E813-BB99-48C6-B662-A46EB21E6E85Q42118121-FCC6195E-809E-49F0-AE3C-7CE8AC61C002Q42514613-787C04C0-3242-40E4-9079-A1843F0BF9F1Q50131982-27B0ECA5-44BB-4E8E-8255-FB15BC793112Q50984708-E9CEB96D-1D14-4716-9146-8F945E77538C
P2860
Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: a one year prospective study.
description
1998 nî lūn-bûn
@nan
1998 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Serum concentrations of cartil ...... a one year prospective study.
@ast
Serum concentrations of cartil ...... a one year prospective study.
@en
type
label
Serum concentrations of cartil ...... a one year prospective study.
@ast
Serum concentrations of cartil ...... a one year prospective study.
@en
prefLabel
Serum concentrations of cartil ...... a one year prospective study.
@ast
Serum concentrations of cartil ...... a one year prospective study.
@en
P2093
P2860
P356
P1476
Serum concentrations of cartil ...... a one year prospective study.
@en
P2093
Conrozier T
Heinegård D
P2860
P304
P356
10.1136/ARD.57.9.527
P407
P577
1998-09-01T00:00:00Z